Skip to main content

Table 3 Patient treatment details (n = 16)

From: Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors

Variable - 1st line n (%), median (range)
Initial management at diagnosis of ULMS  
Surgical resection alone 3 (19%)
Surgical resection and BSO 13 (81%)
Number of prior chemotherapy regimens  
0 12 (75%)
1 2 (12.5%)
2 2 (12.5%)
Prior exogenous estrogens  
Tamoxifen 3 (19%) , 60 months
HRT 4 (25%), 48 months (24–96)
Prior pelvic radiotherapy 1 (6%)
Median interval between diagnosis (surgery) and letrozole initiation 37 months (2–308)
  1. ULMS, uterine leiomyosarcoma; BSO, bilateral salpingo-oophorectomy; HRT, hormonal replacement therapy.